Home > Boards > US Listed > Biotechs >

Viking Therapeutics, Inc. (VKTX)

Add VKTX Price Alert      Hide Sticky   Hide Intro
Moderator: DMOST, greens12
Search This Board: 
Last Post: 3/22/2019 8:48:03 PM - Followers: 74 - Board type: Free - Posts Today: 0

Novel therapeutics for metabolic<Br/>and endocrine disorders
  1. 2


Viking Therapeutics is focused on the development of novel therapeutics for patients suffering from metabolic and endocrine disorders.

Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. Viking’s research and development activities leverage the Company’s expertise in metabolism to develop innovative therapeutics that improve patients’ lives. The Company’s lead clinical program is VK5211, an orally available, non-steroidal selective androgen receptor modulator, or SARM, for the treatment of patients recovering from non-elective hip fracture surgery. The Company’s second program is focused on the development of first-in-class, selective, small molecule agonists of the thyroid receptor beta, or TRß, for adrenoleukodystrophy, or ALD, and lipid disorders such as hypercholesterolemia and non-alcoholic steatohepatitis, or NASH. Viking is also developing additional programs targeted at diabetes, metabolic diseases and anemia.



We have a portfolio of five drug candidates in clinical trials or preclinical studies

Our lead clinical program, VK5211, is a novel, orally available, non-steroidal selective androgen receptor modulator, or SARM, in development for the treatment of patients recovering from non-elective hip fracture surgery. VK5211 is designed to produce the therapeutic benefits of testosterone in muscle and bone with improved safety, tolerability and patient acceptance. We have initiated a Phase 2 clinical trial with VK5211 in patients recovering from non-elective hip fracture surgery. For more information on this study please visit NCT02578095.

Our second pipeline program is focused on the development of novel small molecule agonists of the thyroid beta (TRb) receptor, VK2809 and VK0214. These novel TRb agonists are being developed for hypercholesterolemia and fatty liver disease and X-linked adrenoleukodystrophy, or X-ALD. We have initiated Phase 2 clinical development of VK 2809 in hypercholesterolemia and fatty liver disease. VK0214 is in preclinical development for X-ALD.

We are also developing VK0612, a first-in-class, orally available drug 

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VKTX News: Securities Registration: Employee Benefit Plan (s-8) 03/13/2019 06:56:18 PM
VKTX News: Annual Report (10-k) 03/13/2019 05:04:25 PM
VKTX News: Current Report Filing (8-k) 03/13/2019 04:14:40 PM
VKTX News: Viking Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update 03/13/2019 04:05:00 PM
VKTX News: Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2018 on March 13, 2019 03/06/2019 07:30:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#1675  Sticky Note Viking Has A More Attractive M&A Valuation Than DMOST 11/20/18 09:57:00 AM
#1750   Schedule of events and goals for the remaining Fress 03/22/19 08:48:03 PM
#1749   VKTX presentation-slideshow https://seekingalpha.com/article/4250344-viking-ther greens12 03/21/19 07:14:43 PM
#1748   current market cap around 600 mil. jdlamont 03/20/19 12:25:40 AM
#1746   VKTX ...They could buy back some of the shares DMOST 03/18/19 12:50:00 PM
#1745   Don't forget LGND just raised $800 mil, WHY? jdlamont 03/18/19 12:12:47 PM
#1744   VKTX .....Many agree. DMOST 03/17/19 06:25:08 PM
#1743   I still wish they would have done a greens12 03/17/19 12:07:05 AM
#1742   Edited Transcript of VKTX earnings conference call or DMOST 03/16/19 02:13:07 AM
#1741   VKTX: Phase 2b Trial for VK2809 to Initiate 2H19… DMOST 03/15/19 05:00:52 AM
#1739   Brian is not going to give away the greens12 03/07/19 06:43:37 PM
#1738   ligand could use the proceeds of the sale jdlamont 03/07/19 08:31:21 AM
#1737   ligand sells drug it received 219 million in jdlamont 03/07/19 08:18:44 AM
#1736   LPCN Result of NASH and ABPM study due whatisthecolorofmone 03/03/19 12:36:27 PM
#1735   THANKS!.......VKTX. Viking: The latest 13F filing showed that Viking DMOST 03/03/19 08:10:24 AM
#1734   CymaBay And Viking Therapeutics In NASH, And The greens12 03/01/19 07:04:05 PM
#1733   looks like there is support around 50mda greens12 03/01/19 07:02:14 PM
#1732   Is Viking Therapeutics a Buy? DMOST 02/28/19 05:56:47 AM
#1731   Looks like those who RECENTLY tried use breaking now invest 02/27/19 02:09:07 PM
#1728   None of any substance known, short term, other DMOST 02/20/19 12:52:23 PM
#1727   Question...is there a short term catalyst or forward bUrRpPPP! 02/20/19 11:25:36 AM
#1726   Reason? huge speculation towards a negative outcome. DMOST 02/20/19 06:55:00 AM
#1725   Yeah, I like that 43 price target, too! mauiguy2 02/19/19 07:08:26 PM
#1724   mauiguy2 02/19/19 07:08:26 PM
#1723   mauiguy2 02/19/19 07:06:03 PM
#1722   To be candid all these hyper articles do kris_kade 02/19/19 06:33:14 PM
#1721   4 Healthcare Stocks Looking to Start Strong on DMOST 02/19/19 11:30:55 AM
#1720   Think some want to hold it back??!!! now invest 02/19/19 10:19:35 AM
#1719   Very strange morning so far. It was in mauiguy2 02/19/19 10:04:58 AM
#1718   NICE VOLUME TODAY!!!! COULD MOVE IT HIGHER...... now invest 02/19/19 09:43:29 AM
#1717   YEAP!............. GO VKTX DMOST 02/15/19 10:41:37 AM
#1716   Raymond James has it as a strong buy now invest 02/14/19 07:16:43 PM
#1715   Should You Buy Viking Therapeutics After Gilead Drug Failure? DMOST 02/14/19 06:19:04 PM
#1714   * * $VKTX Video Chart 02-13-2019 * * ClayTrader 02/13/19 05:21:27 PM
#1713   * * $VKTX Video Chart 02-12-2019 * * ClayTrader 02/12/19 05:19:18 PM
#1712   Here's Why Viking Therapeutics Rose as Much as DMOST 02/12/19 03:34:14 PM
#1711   These Healthcare Stocks Could Surpass Investor Expectations DMOST 02/12/19 03:30:11 PM
#1710   Viking Therapeutics Breaks Out After Gilead's Clinical Failure DMOST 02/12/19 11:40:17 AM
#1709   I'm with you. Although I wish I IRAHopeful 02/11/19 11:34:57 PM
#1708   Does anyone know if any catalyst events coming Sncgolf03 02/08/19 09:18:31 AM
#1707   VKTX: No Cardio Toxicity Concerns for VK2809 DMOST 01/23/19 08:23:33 PM
#1706   Viking Therapeutics Regains Ground After Bearish Citron Report DMOST 01/17/19 05:26:07 PM
#1705   Viking Therapeutics, Inc. (VKTX) ........10k annual DMOST 01/17/19 12:55:00 PM
#1704   Are there more recent sales of VKTX shares n4807g 01/17/19 11:31:24 AM
#1703   Citron Says Ligand Has 80% Downside in Explosive Note DMOST 01/17/19 10:58:10 AM
#1702   Ligand has just continued to sell out all DMOST 01/16/19 09:28:26 PM
#1701   Here's Why Ligand Pharmaceuticals Plummeted 16% Today DMOST 01/16/19 09:05:04 PM
#1700   Ligands..........They have been the ones trading us down, DMOST 01/16/19 05:48:55 PM
#1699   The $35 billion race to cure a silent greens12 12/30/18 10:42:51 AM
#1698   Why Viking Therapeutics Sank Today DMOST 12/27/18 07:40:36 PM